World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
15183
World Ranking
5441
National Ranking
172

Overview

Weiyue Lu is affiliated with Fudan University in China and has contributed extensively to the fields of biochemistry, genetics, molecular biology, and medicine. Their research spans several subfields including molecular biology, biomaterials, pharmaceutical science, biomedical engineering, and immunology.

Their work mainly addresses topics such as nanoparticle-based drug delivery, RNA interference and gene delivery, advanced drug delivery systems, advanced biosensing and bioanalysis techniques, nanoplatforms for cancer theranostics, immunotherapy and immune responses, and lipid membrane structure and behavior.

Frequent co-authors collaborating with Weiyue Lu include Cao Xie, Linwei Lu, Jianfen Zhou, Gang Wei, and Changyou Zhan.

Publication venues where Lu has frequently contributed encompass the following:

  • Journal of Controlled Release
  • Acta Pharmaceutica Sinica B
  • Pharmaceutics
  • Nano Letters
  • Biomaterials

Recent publications by Weiyue Lu demonstrate a focus on nanomedicine and targeted therapies:

  • Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined, 2020, ACS Nano
  • Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy, 2020, Journal of Controlled Release
  • Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma, 2021, Acta Biomaterialia
  • Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines, 2020, Journal of Controlled Release
  • Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma, 2020, Journal of Controlled Release

Best Publications

  • Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

    Changyou Zhan;Bing Gu;Cao Xie;Jin Li

  • Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy.

    Quanyin Hu;Quanyin Hu;Wujin Sun;Jinqiang Wang;Jinqiang Wang;Huitong Ruan

  • Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma

    Zhilan Chai;Danni Ran;Linwei Lu;Changyou Zhan

  • Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles

    Ronnie H. Fang;Che Ming J Hu;Kevin N H Chen;Brian T. Luk

  • Brain-targeted drug delivery by manipulating protein corona functions.

    Zui Zhang;Juan Guan;Zhuxuan Jiang;Yang Yang

  • Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II

    Erik de Leeuw;Changqing Li;Pengyun Zeng;Chong Li

  • D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

    Min Liu;Chong Li;Marzena Pazgier;Changqing Li

  • Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.

    Huihui Yan;Lu Wang;Jiyao Wang;Xiaofu Weng

  • Brain tumor-targeted drug delivery strategies.

    Xiaoli Wei;Xishan Chen;Man Ying;Weiyue Lu

  • A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery

    Zhilan Chai;Xuefeng Hu;Xiaoli Wei;Changyou Zhan

  • A Dual‐Bioresponsive Drug‐Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade

    Huitong Ruan;Quanyin Hu;Quanyin Hu;Di Wen;Di Wen;Qian Chen;Qian Chen

  • A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery.

    Xiaoli Wei;Changyou Zhan;Qing Shen;Wei Fu

  • LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.

    Guopei Luo;Xianjun Yu;Chen Jin;Feng Yang

  • Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.

    Xiaoli Wei;Jie Gao;Ronnie H. Fang;Brian T. Luk

  • Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine receptor ligand.

    Changyou Zhan;Bian Li;Luojuan Hu;Xiaoli Wei

  • Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.

    Chong Li;Marzena Pazgier;Changqing Li;Weirong Yuan

  • Recent advances in brain tumor-targeted nano-drug delivery systems

    Yu Liu;Weiyue Lu

  • In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin

    Zhepeng Liu;Weiyue Lu;Lisheng Qian;Xuhui Zhang

  • LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor

    Zhiqiang Yan;Fei Wang;Ziyi Wen;Changyou Zhan

  • Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.

    Yu Liu;Yi-ying Zhu;Gang Wei;Wei-yue Lu

Frequent Co-Authors

Wuyuan Lu
Wuyuan Lu University of Maryland, Baltimore
Liangfang Zhang
Liangfang Zhang University of California, San Diego
Weiwei Gao
Weiwei Gao University of California, San Diego
Jie Song
Jie Song Emory University
Zhen Gu
Zhen Gu Zhejiang University
Qian Chen
Qian Chen Nanjing University of Science and Technology
Robert I. Lehrer
Robert I. Lehrer University of California, Los Angeles
Hao Wang
Hao Wang Swinburne University of Technology
Quanyin Hu
Quanyin Hu University of North Carolina at Chapel Hill
Ernst Wagner
Ernst Wagner Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Weiyue Lu

Trending Scientists

Recently Published Articles